By Staff Writer - April 12, 2022
Every year, the American Association for Cancer Research Annual Meeting brings scientists from around the world together to highlight the latest discoveries across the spectrum of cancer research. These advances span population science and cancer prevention, basic science and cancer biology, translational science and clinical trials, and survivorship and advocacy. The work being done to foster cancer research, treatment and prevention takes center stage.
After going virtual during the COVID-19 pandemic, the world’s largest meeting dedicated to cancer research is convening in New Orleans while also offering a virtual platform. Thousands of presentations, educational sessions and workshops will be highlighted.
Moffitt Cancer Center has more than 60 presentations during this year’s annual meeting. The studies cover a variety of science including adaptive therapy improving treatment for prostate cancer, outcomes for younger colorectal cancer patients, radiomics to help guide ovarian cancer treatment decisions, and ways to better meet the needs of LGBT patients.
Read Moffitt's AACR Stories
Black and Latino Cancer Patients with COVID-19 Faced More Treatment Delays During Pandemic
Moffitt study shows racial and ethnic disparities among cancer patients who contracted the virus
Is Adaptive Therapy in Prostate Cancer Patients a Promising Treatment?
Results of Moffitt-initiated phase 2a clinical trial suggest it can prolong cancer progression
Do Younger Colorectal Cancer Patients Have Worse Outcomes?
A new Moffitt study looks at age-related disparities in treatment outcomes
What is the Link Between HPV and Oropharyngeal Cancer?
Moffitt researchers want to learn why some men present with an oral HPV that clears on its own while others do not
Imaging May Help Guide Ovarian Cancer Treatment Decisions
Moffitt study finds radiomic feature that may predict best first-line treatment approach for these patients
Sexual, Gender Minority Patients Report More Concerns Starting Cancer Treatment
Psychosocial issues, low quality of life could be addressed with early interventions, Moffitt study shows
Phase 2 Bladder Cancer Trial Shows Promising Results
Preliminary data were presented at 2022 AACR Annual Meeting